Atlas Trials

CML, Chronic Phase

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch CML, Chronic Phase

RecordFirmDate
A Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (NCT05367765)Jiangsu Hansoh Pharmaceutical Co., Ltd.2022-04-30
A Study of HS-10382 in Patients With Chronic Myeloid Leukemia. (NCT05367700)Jiangsu Hansoh Pharmaceutical Co., Ltd.2022-04-28
A Study of the Efficacy and Safety of Flumatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase. (NCT05353205)Jiangsu Hansoh Pharmaceutical Co., Ltd.2021-11-23
Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients (NCT03885830)UNC Lineberger Comprehensive Cancer Center2019-06-20
A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs (NCT03459534)Il-Yang Pharm. Co., Ltd.2018-06-25
Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment (NCT04883125)Mansoura University2018-01-01
Study to Assess Efficacy and Safety of Inecalcitol in Imatinib-Treated Residual Chronic Myeloid Leukaemia: INIM Study (NCT02949570)Hybrigenics Corporation2014-02-01

Track CML, Chronic Phase automatically

Every clearance here is in the API, with alerts when new ones post.